| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $299.5M | -9.6% |
| Cost of Revenue | $232.6M | -0.3% |
| R&D Expense | $14.5M | -26.8% |
| SG&A Expense | $75.0M | +1.6% |
| Operating Income | -$69.0M | +0.5% |
| Pre-tax Income | -$76.9M | +1.9% |
| Income Tax | $389K | -38.0% |
| Net Income | -$147.5M | -86.6% |
| EPS (Basic) | -$6.07 | -79.1% |
| EPS (Diluted) | -$6.07 | -79.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $70.0M | +624.2% |
| Accounts Receivable | $19.3M | -43.5% |
| Inventory | $6.6M | +20.6% |
| Current Assets | $170.3M | +89.4% |
| Total Assets | $384.1M | -23.1% |
| Current Liabilities | $102.1M | +38.1% |
| Total Liabilities | $441.2M | -0.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.4M | -52.4% |
| Capital Expenditures | $2.3M | -31.8% |
| Investing Cash Flow | $91.3M | +359.4% |
| Financing Cash Flow | -$32.0M | -562.1% |
| Free Cash Flow | $5.1M | -58.1% |
| Stockholders' Equity |
| -$57.0M |
| -202.3% |